New York's Tyme Jumps as Pancreatic Cancer Drug Shines in Early-Stage Study Post author:Sam Post published:January 18, 2018 Post category:BioPharma The data was presented at the 2018 ASCO Gastrointestinal Cancers Symposium in San Francisco, Calif. today. Source: BioSpace You Might Also Like Genentech Gets a Phase III Win With Hemophila A Drug Hemlibra November 19, 2017 Bay Area's Coherus Dealt Another Blow as Daiichi Sankyo Discontinues Work on RA Drug July 4, 2017 Maryland's Precision Medicine Group Lands $275M December 26, 2017